Physician profile
Daniel E Ramirez
NPI 1386933000
$6,807.18
in general payments reported to CMS, 2019-2025
37 companies · $1,188 in 2025
The $1,188 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2020: $389 · 2021: $482 · 2022: $1,672 · 2023: $727 · 2024: $1,602 · 2025: $1,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,198 · Travel and Lodging: $1,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,198.49 |
| Travel and Lodging | $1,318.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $2,235.01 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $1,335.72 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Thoracic Endoprosthesis |
| Bard Peripheral Vascular, INC. | $433.17 | 2019-2024 | Fluency Endovascular Stent Graft |
| Penumbra, INC. | $271.26 | 2022 | |
| Getinge USA Sales, LLC | $264.76 | 2019-2022 | |
| Medtronic Vascular, INC. | $254.82 | 2019 | |
| Surmodics, INC. | $236.95 | 2022-2025 | Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Medtronic, INC. | $207.84 | 2022-2025 | Hawkone, In.Pact Av |
| Bolton Medical INC | $142.68 | 2020-2021 | |
| Sanara Medtech INC. | $137.35 | 2023 | Celleraterx |
| Cook Medical LLC | $130.45 | 2021 | |
| Philips North America LLC | $116.16 | 2022 | |
| Janssen Pharmaceuticals, INC | $93.09 | 2019-2021 | |
| Organogenesis INC. | $85.70 | 2024-2025 | Puraply Wound Matrix |
| Heartflow, INC. | $82.90 | 2023 | Ffrct |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $76.49 | 2024-2025 | Enroute Transcarotid Stent, Eluvia, Varithena Administration Pack |
| Angiodynamics, INC. | $70.48 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $65.09 | 2023-2024 | Supera, Esprit |
| E.R. Squibb & Sons, L.L.C. | $60.96 | 2025 | Eliquis, Camzyos |
| Aroa Biosurgery Incorporated | $51.19 | 2024 | |
| Biotissue Holdings INC. | $46.96 | 2024 | |
| Smith+Nephew, INC. | $43.28 | 2024 | Pico 14, Collagenase Santyl |
| Imperative Care, INC | $40.42 | 2025 | Symphony Catheter |
| Stryker Corporation | $35.72 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Access Pro Medical, LLC | $32.18 | 2025 | Matriderm |
| Allergan, INC. | $30.95 | 2020-2021 | |
| Atricure, INC. | $29.74 | 2022 | |
| Humacyte Global, INC. | $26.57 | 2025 | Symvess |
| Vivus LLC | $22.81 | 2025 | Pancreaze |
| Cvrx, INC. | $21.82 | 2023 | Barostim Neo System |
| Asahi Intecc USA, INC. | $20.51 | 2025 | Asahi Peripheral Vascular Wires |
| Bsn Medical INC | $19.98 | 2024 | |
| Lemaitre Vascular, INC. | $18.71 | 2019 | |
| Novo Nordisk INC | $17.23 | 2025 | Ozempic |
| Kerecis Limited | $16.63 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Kci USA, INC. | $15.98 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.